Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|July 17, 2009
Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?Vassilios Memtsas, Apostolos Zarros, Stamatios TheocharisEuropean Heart Journal. Case Reports|October 30, 2019
Echocardiographic and radiological evaluation of an unusual aortic root mass in an asymptomatic patient: a case reportVassilios Memtsas, Naveen Sharma, Mary LynchClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 8, 2023
Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3)Rahim Kanji, Joshua Leader, Vassilios Memtsas, et al.International Journal of Molecular Sciences|June 2, 2021
Fibrinolysis in Platelet ThrombiRahim Kanji, Ying X Gue, Vassilios Memtsas, et al.Journal of the American College of Cardiology|May 10, 2023
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial InfarctionRahim Kanji, Ying X Gue, Vassilios Memtsas, et al.Thrombosis and Haemostasis|December 29, 2023
Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjectsJung-Won Suh, Vassilios Memtsas, Ying X Gue, et al.Metabolic Brain Disease|September 19, 2015
Exposure to ethanol during neurodevelopment modifies crucial offspring rat brain enzyme activities in a region-specific mannerVasileios Stolakis, Charis Liapi, Apostolos Zarros, et al.Thrombosis Research|March 6, 2024
Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R studyYing X Gue, Vassilios Memtsas, Rahim Kanji, et al.Pageof 1